BAYER AKTIENGESELLSCHAFT The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 18/07/2019 13:09 BAYER AKTIENGESELLSCHAFT Strategic plans, profit forecasts and presentations Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with colorectal cancer Register number: 280294